Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
722,308
-
Share change
-
-56,653
-
Total reported value
-
$3,558,000
-
Price per share
-
$4.93
-
Number of holders
-
18
-
Value change
-
-$484,383
-
Number of buys
-
6
-
Number of sells
-
9
Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS (GLMD) as of Q1 2016
As of 31 Mar 2016,
GALMED PHARMACEUTICALS LTD - SHS (GLMD) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
722,308 shares.
The largest 10 holders included
683 Capital Management, LLC, Park West Asset Management LLC, PERCEPTIVE ADVISORS LLC, Knoll Capital Management, LP, GRT CAPITAL PARTNERS L.L.C., Menta Capital LLC, DAFNA Capital Management LLC, CapWealth Advisors, LLC, GOLDMAN SACHS GROUP INC, and DRILL CRAIG A.
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.